Zhejiang Shouxiangu - Public Comps and Valuation Multiples

Zhejiang Shouxiangu Overview

About Zhejiang Shouxiangu

Zhejiang Shouxiangu Pharmaceutical Co Ltd is a Chinese pharmaceutical company.

Founded

2007

HQ

Employees

n/a

Website

sxg1909.com

Sectors

Biopharmaceuticals
BioTech

Financials

LTM Revenue $97.8M

LTM EBITDA $35.2M

EV

$492M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Zhejiang Shouxiangu Financials

As of November 2025, Zhejiang Shouxiangu reported last 12-month revenue of $97.8M and EBITDA of $35.2M.

In the same period, Zhejiang Shouxiangu generated $79.0M in LTM gross profit and $24.7M in net income.

See Zhejiang Shouxiangu valuation multiples based on analyst estimates

Zhejiang Shouxiangu P&L

In the most recent fiscal year, Zhejiang Shouxiangu reported revenue of $97.8M and EBITDA of $38.0M.

Zhejiang Shouxiangu expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Zhejiang Shouxiangu valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$97.8M	XXX	$97.8M	XXX	XXX	XXX
Gross Profit	$79.0M	XXX	$79.0M	XXX	XXX	XXX
Gross Margin	81%	XXX	81%	XXX	XXX	XXX
EBITDA	$35.2M	XXX	$38.0M	XXX	XXX	XXX
EBITDA Margin	36%	XXX	39%	XXX	XXX	XXX
EBIT	$15.7M	XXX	$19.8M	XXX	XXX	XXX
EBIT Margin	16%	XXX	20%	XXX	XXX	XXX
Net Profit	$24.7M	XXX	$24.7M	XXX	XXX	XXX
Net Margin	25%	XXX	25%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Zhejiang Shouxiangu including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $97.8M. EBITDA for the last twelve months was $35.2M. In the most recent fiscal year, Zhejiang Shouxiangu achieved $97.8M in revenue and $38.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$97.8M	Analyst estimates available to subscribers	$97.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$79.0M	Analyst estimates available to subscribers	$79.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	80.8% gross margin	Analyst estimates available to subscribers	80.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$35.2M	Analyst estimates available to subscribers	$38.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	36.0% EBITDA margin	Analyst estimates available to subscribers	38.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$15.7M	Analyst estimates available to subscribers	$19.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	16.0% EBIT margin	Analyst estimates available to subscribers	20.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$24.7M	Analyst estimates available to subscribers	$24.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	25.3% net profit margin	Analyst estimates available to subscribers	25.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Zhejiang Shouxiangu

This financial data table provides comprehensive performance metrics for Zhejiang Shouxiangu, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Zhejiang Shouxiangu generated $97.8M in revenue over the last twelve months.
The company achieved $35.2M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $79.0M.
Net income over the last twelve months reached $24.7M.

Fiscal Year Performance

In the most recent fiscal year, Zhejiang Shouxiangu reported $97.8M in total revenue.
Fiscal year EBITDA was $38.0M.
The company maintained a gross profit margin of 80.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 38.8%.
Net profit margin reached 25.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Zhejiang Shouxiangu. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Zhejiang Shouxiangu Stock Performance

Zhejiang Shouxiangu has current market cap of CNY 4.0B (or $564M), and EV of CNY 3.5B (or $492M).

Market Cap Evolution

Zhejiang Shouxiangu Stock Data

As of December 5, 2025, Zhejiang Shouxiangu's stock price is CNY 20 (or $3).

See Zhejiang Shouxiangu trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$492M	$564M	XXX	XXX	XXX	XXX	$0.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Zhejiang Shouxiangu Valuation Multiples

Zhejiang Shouxiangu's trades at 5.0x EV/Revenue multiple, and 13.0x EV/EBITDA.

See valuation multiples for Zhejiang Shouxiangu and 15K+ public comps

Zhejiang Shouxiangu Financial Valuation Multiples

As of December 5, 2025, Zhejiang Shouxiangu has market cap of $564M and EV of $492M.

Equity research analysts estimate Zhejiang Shouxiangu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Zhejiang Shouxiangu has a P/E ratio of 22.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$564M	XXX	$564M	XXX	XXX	XXX
EV (current)	$492M	XXX	$492M	XXX	XXX	XXX
EV/Revenue	5.0x	XXX	5.0x	XXX	XXX	XXX
EV/EBITDA	14.0x	XXX	13.0x	XXX	XXX	XXX
EV/EBIT	31.3x	XXX	24.8x	XXX	XXX	XXX
EV/Gross Profit	6.2x	XXX	n/a	XXX	XXX	XXX
P/E	22.8x	XXX	22.8x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-11.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Zhejiang Shouxiangu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Zhejiang Shouxiangu Margins & Growth Rates

Zhejiang Shouxiangu's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Zhejiang Shouxiangu's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Zhejiang Shouxiangu's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Zhejiang Shouxiangu and other 15K+ public comps

Zhejiang Shouxiangu Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	36%	XXX	39%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	33%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	7%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	60%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial